Login

Deciphera Pharmaceuticals, Inc. 4 SEC Filings

Filed On Filing
11 Jun 2024 Form 4: Sherman Matthew L, EVP & Chief Medical Officer

Received 34,157 shares as a grant or award · Returned 72,029 shares to the issuer · Disposed of 72,261 shares (Tender Offer) · 1 more

11 Jun 2024 Form 4: Kelly Thomas Patrick, Chief Financial Officer

Received 34,157 shares as a grant or award · Returned 72,029 shares to the issuer · Disposed of 42,478 shares (Tender Offer) · 1 more

11 Jun 2024 Form 4: Pitman Jama, SVP, Chief Development Officer

Received 20,163 shares as a grant or award · Returned 53,951 shares to the issuer · Disposed of 34,243 shares (Tender Offer) · 1 more

11 Jun 2024 Form 4: Friedman Franklin Stuart, Director

Disposed of 10,000 shares (Tender Offer) · Disposed of 66,066 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Kelley Susan L., Director

Disposed of 85,339 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Dhanak Dashyant, EVP & Chief Scientific Officer

Received 25,913 shares as a grant or award · Returned 184,088 shares to the issuer · Disposed of 135,000 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Martin John Richard, Director

Disposed of 112,500 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Martin Daniel C., Chief Commercial Officer

Received 20,163 shares as a grant or award · Returned 43,951 shares to the issuer · Disposed of 31,330 shares (Tender Offer) · 1 more

11 Jun 2024 Form 4: Walsh Dennis Leo, Director

Disposed of 11,000 shares (Tender Offer) · Disposed of 130,066 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Bristol James Arthur, Director

Disposed of 159,714 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Squarer Ron, Director

Disposed of 66,066 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Allen Patricia L, Director

Disposed of 95,480 Stock Option (Right to Buy) (Disposition to Issuer)

11 Jun 2024 Form 4: Hoerter Steven L., Director

Received 286,075 shares as a grant or award · Returned 286,075 shares to the issuer · Disposed of 72,763 shares (Tender Offer) · 1 more

11 Jun 2024 Form 4: Benz Edward J. Jr, Director

Disposed of 102,914 Stock Option (Right to Buy) (Disposition to Issuer)

24 Apr 2024 Form 4: Brightstar Associates Llc, 10% owner

Received 48,136 shares by exercise ($481)

20 Feb 2024 Form 4: Sherman Matthew L, EVP & Chief Medical Officer

Received 17,275 shares as a grant or award · Granted 69,100 Stock Option (Right to Buy) · Sold 2,615 shares ($40.8K)

20 Feb 2024 Form 4: Kelly Thomas Patrick, Chief Financial Officer

Received 17,275 shares as a grant or award · Granted 69,100 Stock Option (Right to Buy) · Sold 3,010 shares ($47K)

20 Feb 2024 Form 4: Pitman Jama, SVP, Chief Development Officer

Received 19,725 shares as a grant or award · Granted 38,900 Stock Option (Right to Buy) · Sold 2,267 shares ($35.4K)

20 Feb 2024 Form 4: Hoerter Steven L., Director

Granted 298,100 Stock Option (Right to Buy)

20 Feb 2024 Form 4: Dhanak Dashyant, EVP & Chief Scientific Officer

Received 17,275 shares as a grant or award · Granted 69,100 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support